医生和警察被拘留.

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Bone marrow transplantation·2021

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma.

Endocrine-related cancer·2019

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.

Disease models & mechanisms·2016

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.

Bone marrow transplantation·2015

Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.

British journal of cancer·2015

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Prior Authorization: Moving Toward Zero.

NEJM catalyst innovations in care delivery·2026

Administrative Burden as a Potential Cause of Financial Hardship and Poor Mental Health in Cancer: A Mixed Methods Study.

JCO oncology practice·2026

Change in Volume of Contacts to the National Call Center for Homeless Veterans After the US Supreme Court Ruling on <i>Grants Pass v Johnson</i>.

Public health reports (Washington, D.C. : 1974)·2026

Judicial substitute consent for medical procedures in adults lacking decision-making capacity: a five-year experience from a Polish tertiary hospital.

BMC medical ethics·2026

PHDReader: police handwritten document recognition method based on VLM with EI-LFT using FP-EESR and MFE-GLS.

Scientific reports·2026

Assessing compliance with smoke-free laws in Purbakhola Rural Municipality, Nepal: A cross-sectional observational study.

PLOS global public health·2026

相关实验视频

医生和警察被拘留.

相关概念视频

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma.

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†.

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.

Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Prior Authorization: Moving Toward Zero.

Administrative Burden as a Potential Cause of Financial Hardship and Poor Mental Health in Cancer: A Mixed Methods Study.

Change in Volume of Contacts to the National Call Center for Homeless Veterans After the US Supreme Court Ruling on <i>Grants Pass v Johnson</i>.

Judicial substitute consent for medical procedures in adults lacking decision-making capacity: a five-year experience from a Polish tertiary hospital.

PHDReader: police handwritten document recognition method based on VLM with EI-LFT using FP-EESR and MFE-GLS.

Assessing compliance with smoke-free laws in Purbakhola Rural Municipality, Nepal: A cross-sectional observational study.

相关实验视频

医生和警察被拘留.

相关概念视频

相关文章